Allogenic Umbilical Cord-derived Mesenchymal Stem Cell therapy (Seoul National University Hospital)

N/A

Report date: 2025/02/07 20:00:46

Base Information

Drug NameAllogenic Umbilical Cord-derived Mesenchymal Stem Cell therapy (Seoul National University Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacementsImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsShoulder Impingement Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSeoul National University Hospital - Abu Dhabi

China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University Hospital

Inactive CompaniesN/A

Active IndicationsShoulder Impingement Syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A